newsfilter
← Latest News
Business Wire·

Tempus Receives FDA Clearance for its AI Product Intended to Detect Signs of Pulmonary Hypertension From Standard ECGs

ECG-PH clearance adds pulmonary hypertension to Tempus’ FDA-cleared AI products for atrial fibrillation and low ejection fraction Tempus AI, Inc. (NASDAQ:TEM) today announced it has received 510(k) clearance from the